Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramon Baeza-Trinidad

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Cardiovascular Medicine|February 5, 2026
Commentary: Bendopnea as an independent prognostic marker for adverse events in hospitalized heart failure patients: insights from a multicenter prospective cohort studyRamon Baeza-Trinidad
Internal Medicine Journal|March 21, 2022
Novel cystic fibrosis transmembrane conductance regulator variant in a cystic fibrosis patientRamon Baeza-Trinidad, Sandra Garcia-Guerreros
The New England Journal of Medicine|July 20, 2022
Nonketotic Hyperglycemic HemichoreaJorge Collado-Saenz, Ramon Baeza-Trinidad
Thrombosis Research|February 11, 2026
A real-world evaluation of the safety of edoxaban in frail older adults with non-valvular atrial fibrillationAlvaro Hermida-Ameijeiras, Nestor Vazquez-Agra, Carlos Rodriguez-Pascual, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Cardiovascular Medicine|February 5, 2026
Commentary: Bendopnea as an independent prognostic marker for adverse events in hospitalized heart failure patients: insights from a multicenter prospective cohort studyRamon Baeza-Trinidad
Internal Medicine Journal|March 21, 2022
Novel cystic fibrosis transmembrane conductance regulator variant in a cystic fibrosis patientRamon Baeza-Trinidad, Sandra Garcia-Guerreros
The New England Journal of Medicine|July 20, 2022
Nonketotic Hyperglycemic HemichoreaJorge Collado-Saenz, Ramon Baeza-Trinidad
Thrombosis Research|February 11, 2026
A real-world evaluation of the safety of edoxaban in frail older adults with non-valvular atrial fibrillationAlvaro Hermida-Ameijeiras, Nestor Vazquez-Agra, Carlos Rodriguez-Pascual, et al.
Pageof 1